nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—DRD2—nicotine dependence	0.666	1	CbGaD
Amoxapine—ORM1—saliva—nicotine dependence	0.0105	0.186	CbGeAlD
Amoxapine—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00643	0.0584	CcSEcCtD
Amoxapine—Delusion—Varenicline—nicotine dependence	0.00471	0.0428	CcSEcCtD
Amoxapine—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00443	0.0402	CcSEcCtD
Amoxapine—Mydriasis—Varenicline—nicotine dependence	0.00418	0.038	CcSEcCtD
Amoxapine—Disturbance in attention—Varenicline—nicotine dependence	0.00385	0.035	CcSEcCtD
Amoxapine—Lacrimation increased—Varenicline—nicotine dependence	0.00362	0.0329	CcSEcCtD
Amoxapine—Coordination abnormal—Varenicline—nicotine dependence	0.0034	0.0309	CcSEcCtD
Amoxapine—Nightmare—Varenicline—nicotine dependence	0.00322	0.0293	CcSEcCtD
Amoxapine—Mental disability—Varenicline—nicotine dependence	0.00289	0.0263	CcSEcCtD
Amoxapine—Disorientation—Varenicline—nicotine dependence	0.00271	0.0246	CcSEcCtD
Amoxapine—Libido decreased—Varenicline—nicotine dependence	0.00261	0.0237	CcSEcCtD
Amoxapine—Increased appetite—Varenicline—nicotine dependence	0.00258	0.0234	CcSEcCtD
Amoxapine—Atrial fibrillation—Varenicline—nicotine dependence	0.00256	0.0232	CcSEcCtD
Amoxapine—Cerebrovascular accident—Varenicline—nicotine dependence	0.00247	0.0224	CcSEcCtD
Amoxapine—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.0024	0.0218	CcSEcCtD
Amoxapine—DRD4—brain—nicotine dependence	0.00239	0.0422	CbGeAlD
Amoxapine—Urinary retention—Varenicline—nicotine dependence	0.0023	0.0209	CcSEcCtD
Amoxapine—HTR1B—cardiovascular system—nicotine dependence	0.00199	0.0351	CbGeAlD
Amoxapine—Pollakiuria—Varenicline—nicotine dependence	0.00193	0.0176	CcSEcCtD
Amoxapine—Erectile dysfunction—Varenicline—nicotine dependence	0.00193	0.0175	CcSEcCtD
Amoxapine—DRD1—midbrain—nicotine dependence	0.00192	0.0338	CbGeAlD
Amoxapine—Weight increased—Varenicline—nicotine dependence	0.0019	0.0173	CcSEcCtD
Amoxapine—Acute coronary syndrome—Varenicline—nicotine dependence	0.00184	0.0167	CcSEcCtD
Amoxapine—Myocardial infarction—Varenicline—nicotine dependence	0.00183	0.0166	CcSEcCtD
Amoxapine—Stomatitis—Varenicline—nicotine dependence	0.00182	0.0165	CcSEcCtD
Amoxapine—CHRM1—cardiovascular system—nicotine dependence	0.0018	0.0318	CbGeAlD
Amoxapine—HTR2B—cardiovascular system—nicotine dependence	0.00179	0.0316	CbGeAlD
Amoxapine—DRD3—brain—nicotine dependence	0.00168	0.0297	CbGeAlD
Amoxapine—Hallucination—Varenicline—nicotine dependence	0.00167	0.0151	CcSEcCtD
Amoxapine—Hypoaesthesia—Varenicline—nicotine dependence	0.00167	0.0151	CcSEcCtD
Amoxapine—HTR6—brain—nicotine dependence	0.00162	0.0286	CbGeAlD
Amoxapine—HTR1A—cardiovascular system—nicotine dependence	0.00161	0.0283	CbGeAlD
Amoxapine—Tinnitus—Varenicline—nicotine dependence	0.00156	0.0142	CcSEcCtD
Amoxapine—HTR1B—midbrain—nicotine dependence	0.00155	0.0274	CbGeAlD
Amoxapine—GABRA1—midbrain—nicotine dependence	0.00155	0.0274	CbGeAlD
Amoxapine—SLC6A3—midbrain—nicotine dependence	0.00154	0.0272	CbGeAlD
Amoxapine—HTR7—cardiovascular system—nicotine dependence	0.00153	0.0271	CbGeAlD
Amoxapine—HTR2C—midbrain—nicotine dependence	0.00149	0.0263	CbGeAlD
Amoxapine—ADRA1A—cardiovascular system—nicotine dependence	0.00148	0.0261	CbGeAlD
Amoxapine—Flatulence—Varenicline—nicotine dependence	0.00144	0.0131	CcSEcCtD
Amoxapine—Dysgeusia—Varenicline—nicotine dependence	0.00143	0.013	CcSEcCtD
Amoxapine—SLC6A4—midbrain—nicotine dependence	0.00141	0.0249	CbGeAlD
Amoxapine—Vision blurred—Varenicline—nicotine dependence	0.00137	0.0125	CcSEcCtD
Amoxapine—Tremor—Varenicline—nicotine dependence	0.00137	0.0124	CcSEcCtD
Amoxapine—Agitation—Varenicline—nicotine dependence	0.00134	0.0122	CcSEcCtD
Amoxapine—Syncope—Varenicline—nicotine dependence	0.00131	0.0119	CcSEcCtD
Amoxapine—Palpitations—Varenicline—nicotine dependence	0.00129	0.0117	CcSEcCtD
Amoxapine—Loss of consciousness—Varenicline—nicotine dependence	0.00128	0.0116	CcSEcCtD
Amoxapine—Convulsion—Varenicline—nicotine dependence	0.00126	0.0115	CcSEcCtD
Amoxapine—Hypertension—Varenicline—nicotine dependence	0.00126	0.0114	CcSEcCtD
Amoxapine—HTR1A—midbrain—nicotine dependence	0.00125	0.0221	CbGeAlD
Amoxapine—Asenapine—DRD2—nicotine dependence	0.00123	0.2	CrCbGaD
Amoxapine—Dry mouth—Varenicline—nicotine dependence	0.00121	0.011	CcSEcCtD
Amoxapine—DRD1—brain—nicotine dependence	0.0012	0.0212	CbGeAlD
Amoxapine—HTR7—midbrain—nicotine dependence	0.0012	0.0211	CbGeAlD
Amoxapine—Oedema—Varenicline—nicotine dependence	0.00119	0.0108	CcSEcCtD
Amoxapine—Shock—Varenicline—nicotine dependence	0.00117	0.0106	CcSEcCtD
Amoxapine—Oxazepam—GABRA4—nicotine dependence	0.00117	0.19	CrCbGaD
Amoxapine—Thrombocytopenia—Varenicline—nicotine dependence	0.00117	0.0106	CcSEcCtD
Amoxapine—HTR3A—brain—nicotine dependence	0.00116	0.0205	CbGeAlD
Amoxapine—Tachycardia—Varenicline—nicotine dependence	0.00116	0.0106	CcSEcCtD
Amoxapine—Temazepam—GABRA4—nicotine dependence	0.00116	0.188	CrCbGaD
Amoxapine—Anorexia—Varenicline—nicotine dependence	0.00113	0.0103	CcSEcCtD
Amoxapine—DRD2—midbrain—nicotine dependence	0.00113	0.02	CbGeAlD
Amoxapine—Hypotension—Varenicline—nicotine dependence	0.00111	0.0101	CcSEcCtD
Amoxapine—Insomnia—Varenicline—nicotine dependence	0.00108	0.00978	CcSEcCtD
Amoxapine—Somnolence—Varenicline—nicotine dependence	0.00106	0.00961	CcSEcCtD
Amoxapine—Dyspepsia—Varenicline—nicotine dependence	0.00105	0.00952	CcSEcCtD
Amoxapine—Decreased appetite—Varenicline—nicotine dependence	0.00103	0.0094	CcSEcCtD
Amoxapine—Fatigue—Varenicline—nicotine dependence	0.00103	0.00932	CcSEcCtD
Amoxapine—Constipation—Varenicline—nicotine dependence	0.00102	0.00925	CcSEcCtD
Amoxapine—Feeling abnormal—Varenicline—nicotine dependence	0.000981	0.00891	CcSEcCtD
Amoxapine—HTR1B—brain—nicotine dependence	0.000976	0.0172	CbGeAlD
Amoxapine—GABRA1—brain—nicotine dependence	0.000976	0.0172	CbGeAlD
Amoxapine—Gastrointestinal pain—Varenicline—nicotine dependence	0.000973	0.00884	CcSEcCtD
Amoxapine—SLC6A3—brain—nicotine dependence	0.000968	0.0171	CbGeAlD
Amoxapine—HTR2A—cardiovascular system—nicotine dependence	0.000957	0.0169	CbGeAlD
Amoxapine—Urticaria—Varenicline—nicotine dependence	0.000946	0.00859	CcSEcCtD
Amoxapine—Abdominal pain—Varenicline—nicotine dependence	0.000941	0.00855	CcSEcCtD
Amoxapine—Body temperature increased—Varenicline—nicotine dependence	0.000941	0.00855	CcSEcCtD
Amoxapine—HTR2C—brain—nicotine dependence	0.000936	0.0165	CbGeAlD
Amoxapine—SLC6A4—brain—nicotine dependence	0.000887	0.0156	CbGeAlD
Amoxapine—CHRM1—brain—nicotine dependence	0.000884	0.0156	CbGeAlD
Amoxapine—HTR2B—brain—nicotine dependence	0.000879	0.0155	CbGeAlD
Amoxapine—ADRA2A—midbrain—nicotine dependence	0.000879	0.0155	CbGeAlD
Amoxapine—Asthenia—Varenicline—nicotine dependence	0.000854	0.00776	CcSEcCtD
Amoxapine—Pruritus—Varenicline—nicotine dependence	0.000842	0.00765	CcSEcCtD
Amoxapine—Diarrhoea—Varenicline—nicotine dependence	0.000814	0.0074	CcSEcCtD
Amoxapine—HTR1A—brain—nicotine dependence	0.000788	0.0139	CbGeAlD
Amoxapine—Dizziness—Varenicline—nicotine dependence	0.000787	0.00715	CcSEcCtD
Amoxapine—SLC6A2—brain—nicotine dependence	0.000781	0.0138	CbGeAlD
Amoxapine—Vomiting—Varenicline—nicotine dependence	0.000757	0.00687	CcSEcCtD
Amoxapine—HTR7—brain—nicotine dependence	0.000753	0.0133	CbGeAlD
Amoxapine—Rash—Varenicline—nicotine dependence	0.00075	0.00682	CcSEcCtD
Amoxapine—Dermatitis—Varenicline—nicotine dependence	0.00075	0.00681	CcSEcCtD
Amoxapine—HTR2A—midbrain—nicotine dependence	0.000747	0.0132	CbGeAlD
Amoxapine—Headache—Varenicline—nicotine dependence	0.000746	0.00677	CcSEcCtD
Amoxapine—ADRA1A—brain—nicotine dependence	0.000726	0.0128	CbGeAlD
Amoxapine—Zuclopenthixol—DRD2—nicotine dependence	0.000717	0.117	CrCbGaD
Amoxapine—DRD2—brain—nicotine dependence	0.000712	0.0126	CbGeAlD
Amoxapine—Nausea—Varenicline—nicotine dependence	0.000707	0.00642	CcSEcCtD
Amoxapine—Olanzapine—DRD2—nicotine dependence	0.000683	0.111	CrCbGaD
Amoxapine—HRH1—brain—nicotine dependence	0.000562	0.00991	CbGeAlD
Amoxapine—ADRA2A—brain—nicotine dependence	0.000552	0.00974	CbGeAlD
Amoxapine—HTR2A—brain—nicotine dependence	0.000469	0.00828	CbGeAlD
Amoxapine—CYP2D6—brain—nicotine dependence	0.000428	0.00754	CbGeAlD
Amoxapine—Loxapine—DRD2—nicotine dependence	0.000425	0.069	CrCbGaD
Amoxapine—Quetiapine—DRD2—nicotine dependence	0.000415	0.0674	CrCbGaD
Amoxapine—Clozapine—DRD2—nicotine dependence	0.000357	0.058	CrCbGaD
Amoxapine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000145	0.000902	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—OPRM1—nicotine dependence	0.000144	0.000898	CbGpPWpGaD
Amoxapine—DRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.000144	0.000896	CbGpPWpGaD
Amoxapine—CHRM1—Circadian rythm related genes—DRD2—nicotine dependence	0.000144	0.000896	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000143	0.000892	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000143	0.00089	CbGpPWpGaD
Amoxapine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000143	0.000888	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000143	0.000887	CbGpPWpGaD
Amoxapine—DRD3—GPCR ligand binding—OPRM1—nicotine dependence	0.000142	0.000884	CbGpPWpGaD
Amoxapine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00014	0.000874	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00014	0.000873	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—AKR1B10—nicotine dependence	0.00014	0.000872	CbGpPWpGaD
Amoxapine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00014	0.000872	CbGpPWpGaD
Amoxapine—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00014	0.000869	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000138	0.000856	CbGpPWpGaD
Amoxapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000138	0.000856	CbGpPWpGaD
Amoxapine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000137	0.000854	CbGpPWpGaD
Amoxapine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000137	0.00085	CbGpPWpGaD
Amoxapine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000137	0.000849	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—FGD1—nicotine dependence	0.000136	0.000844	CbGpPWpGaD
Amoxapine—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000135	0.000839	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000132	0.000823	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00013	0.000812	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.00013	0.00081	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00013	0.00081	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00013	0.000808	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.00013	0.000806	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00013	0.000806	CbGpPWpGaD
Amoxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000128	0.000795	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000128	0.000793	CbGpPWpGaD
Amoxapine—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000124	0.00077	CbGpPWpGaD
Amoxapine—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000123	0.000766	CbGpPWpGaD
Amoxapine—HTR6—GPCR ligand binding—DRD2—nicotine dependence	0.000121	0.000752	CbGpPWpGaD
Amoxapine—HTR7—GPCR ligand binding—DRD2—nicotine dependence	0.000121	0.000751	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TAS2R16—nicotine dependence	0.00012	0.000748	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TAS2R16—nicotine dependence	0.00012	0.000747	CbGpPWpGaD
Amoxapine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000119	0.000737	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000118	0.000737	CbGpPWpGaD
Amoxapine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000118	0.000736	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000118	0.000736	CbGpPWpGaD
Amoxapine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000118	0.000733	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000118	0.000732	CbGpPWpGaD
Amoxapine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000118	0.000731	CbGpPWpGaD
Amoxapine—HTR1B—GPCR ligand binding—DRD2—nicotine dependence	0.000118	0.000731	CbGpPWpGaD
Amoxapine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000117	0.000728	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000117	0.000727	CbGpPWpGaD
Amoxapine—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000116	0.000723	CbGpPWpGaD
Amoxapine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000116	0.000722	CbGpPWpGaD
Amoxapine—DRD4—GPCR ligand binding—DRD2—nicotine dependence	0.000116	0.000719	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TAS2R16—nicotine dependence	0.000115	0.000716	CbGpPWpGaD
Amoxapine—HRH4—GPCR downstream signaling—DRD2—nicotine dependence	0.000115	0.000715	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000114	0.000711	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000113	0.0007	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—FGD1—nicotine dependence	0.000112	0.000698	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000112	0.000696	CbGpPWpGaD
Amoxapine—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.00011	0.000687	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.00011	0.000685	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.00011	0.000683	CbGpPWpGaD
Amoxapine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000109	0.000676	CbGpPWpGaD
Amoxapine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000108	0.000671	CbGpPWpGaD
Amoxapine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000107	0.000665	CbGpPWpGaD
Amoxapine—HRH1—GPCR ligand binding—OPRM1—nicotine dependence	0.000107	0.000664	CbGpPWpGaD
Amoxapine—CHRM1—GPCR ligand binding—OPRM1—nicotine dependence	0.000106	0.000662	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000105	0.000652	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—DRD2—nicotine dependence	0.000104	0.000649	CbGpPWpGaD
Amoxapine—DRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000104	0.000648	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000104	0.000646	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000104	0.000644	CbGpPWpGaD
Amoxapine—DRD3—GPCR ligand binding—DRD2—nicotine dependence	0.000103	0.000639	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000102	0.000637	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000102	0.000636	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TAS2R16—nicotine dependence	0.000102	0.000636	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—FGD1—nicotine dependence	0.000102	0.000634	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000102	0.000632	CbGpPWpGaD
Amoxapine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000102	0.000632	CbGpPWpGaD
Amoxapine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000101	0.00063	CbGpPWpGaD
Amoxapine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000101	0.000628	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.0001	0.000622	CbGpPWpGaD
Amoxapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.95e-05	0.000619	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—WASF2—nicotine dependence	9.88e-05	0.000615	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	9.73e-05	0.000605	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—WASF1—nicotine dependence	9.47e-05	0.000589	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—OPRM1—nicotine dependence	9.45e-05	0.000588	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—OPRM1—nicotine dependence	9.44e-05	0.000587	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—FGD1—nicotine dependence	9.44e-05	0.000587	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—FGD1—nicotine dependence	9.43e-05	0.000587	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	9.3e-05	0.000578	CbGpPWpGaD
Amoxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.24e-05	0.000575	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	9.19e-05	0.000571	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—FGD1—nicotine dependence	9.17e-05	0.000571	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—OPRM1—nicotine dependence	9.04e-05	0.000562	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—FGD1—nicotine dependence	9.03e-05	0.000561	CbGpPWpGaD
Amoxapine—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	8.95e-05	0.000557	CbGpPWpGaD
Amoxapine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	8.91e-05	0.000554	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	8.91e-05	0.000554	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	8.86e-05	0.000551	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	8.63e-05	0.000537	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—FGD1—nicotine dependence	8.62e-05	0.000536	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—OPRM1—nicotine dependence	8.59e-05	0.000534	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—OPRM1—nicotine dependence	8.58e-05	0.000533	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—OPRM1—nicotine dependence	8.53e-05	0.00053	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	8.34e-05	0.000519	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—AKR1B10—nicotine dependence	8.34e-05	0.000519	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—AKR1B10—nicotine dependence	8.33e-05	0.000518	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—OPRM1—nicotine dependence	8.21e-05	0.000511	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	8.14e-05	0.000506	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—FGD1—nicotine dependence	8.13e-05	0.000505	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	8.1e-05	0.000504	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—OPRM1—nicotine dependence	8.03e-05	0.000499	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—FGD1—nicotine dependence	8.02e-05	0.000499	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—AKR1B10—nicotine dependence	7.97e-05	0.000496	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	7.84e-05	0.000487	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	7.82e-05	0.000486	CbGpPWpGaD
Amoxapine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	7.73e-05	0.000481	CbGpPWpGaD
Amoxapine—HRH1—GPCR ligand binding—DRD2—nicotine dependence	7.72e-05	0.00048	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	7.69e-05	0.000479	CbGpPWpGaD
Amoxapine—CHRM1—GPCR ligand binding—DRD2—nicotine dependence	7.69e-05	0.000479	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TAS2R16—nicotine dependence	7.68e-05	0.000478	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TAS2R16—nicotine dependence	7.65e-05	0.000476	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	7.61e-05	0.000473	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	7.57e-05	0.000471	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	7.53e-05	0.000469	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	7.39e-05	0.00046	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—OPRM1—nicotine dependence	7.29e-05	0.000454	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	7.18e-05	0.000446	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—AKR1B10—nicotine dependence	7.08e-05	0.000441	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	7.04e-05	0.000438	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	7e-05	0.000435	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	7e-05	0.000435	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—FGD1—nicotine dependence	6.99e-05	0.000435	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.96e-05	0.000433	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	6.95e-05	0.000432	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—DRD2—nicotine dependence	6.83e-05	0.000425	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—DRD2—nicotine dependence	6.83e-05	0.000425	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	6.64e-05	0.000413	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—DRD2—nicotine dependence	6.54e-05	0.000407	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	6.35e-05	0.000395	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	6.32e-05	0.000393	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	6.24e-05	0.000388	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—DRD2—nicotine dependence	6.21e-05	0.000386	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—DRD2—nicotine dependence	6.2e-05	0.000386	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	6.17e-05	0.000384	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—DRD2—nicotine dependence	6.17e-05	0.000384	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	6.14e-05	0.000382	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	6.14e-05	0.000382	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—FGD1—nicotine dependence	6.14e-05	0.000382	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	6.05e-05	0.000376	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	6.04e-05	0.000376	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—OPRM1—nicotine dependence	6.03e-05	0.000375	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	6.03e-05	0.000375	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—FGD1—nicotine dependence	6.02e-05	0.000375	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—OPRM1—nicotine dependence	6.01e-05	0.000374	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—FGD1—nicotine dependence	6e-05	0.000374	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—DRD2—nicotine dependence	5.93e-05	0.000369	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	5.92e-05	0.000368	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	5.91e-05	0.000368	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	5.88e-05	0.000366	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—WASF2—nicotine dependence	5.88e-05	0.000365	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—WASF2—nicotine dependence	5.87e-05	0.000365	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—DRD2—nicotine dependence	5.81e-05	0.000361	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—WASF2—nicotine dependence	5.71e-05	0.000355	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	5.67e-05	0.000352	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—WASF1—nicotine dependence	5.63e-05	0.00035	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—WASF1—nicotine dependence	5.63e-05	0.00035	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—WASF2—nicotine dependence	5.62e-05	0.000349	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	5.58e-05	0.000347	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.5e-05	0.000342	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	5.49e-05	0.000342	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	5.49e-05	0.000341	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—OPRM1—nicotine dependence	5.48e-05	0.000341	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—WASF1—nicotine dependence	5.47e-05	0.00034	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—OPRM1—nicotine dependence	5.46e-05	0.00034	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	5.42e-05	0.000337	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—CYP2A7—nicotine dependence	5.39e-05	0.000336	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—WASF1—nicotine dependence	5.39e-05	0.000335	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	5.38e-05	0.000334	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—WASF2—nicotine dependence	5.36e-05	0.000334	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—DRD2—nicotine dependence	5.34e-05	0.000332	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	5.33e-05	0.000332	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—AKR1B10—nicotine dependence	5.32e-05	0.000331	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—AKR1B10—nicotine dependence	5.3e-05	0.00033	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—DRD2—nicotine dependence	5.27e-05	0.000328	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	5.22e-05	0.000325	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—WASF1—nicotine dependence	5.14e-05	0.00032	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—OPRM1—nicotine dependence	5.07e-05	0.000315	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—OPRM1—nicotine dependence	5.07e-05	0.000315	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	5.06e-05	0.000315	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—WASF2—nicotine dependence	5.06e-05	0.000315	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	5.03e-05	0.000313	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	4.99e-05	0.000311	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—WASF2—nicotine dependence	4.99e-05	0.00031	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	4.93e-05	0.000307	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	4.85e-05	0.000302	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—OPRM1—nicotine dependence	4.85e-05	0.000302	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—WASF1—nicotine dependence	4.85e-05	0.000302	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—WASF1—nicotine dependence	4.78e-05	0.000298	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	4.63e-05	0.000288	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	4.59e-05	0.000286	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	4.57e-05	0.000284	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	4.37e-05	0.000272	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—OPRM1—nicotine dependence	4.37e-05	0.000272	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—DRD2—nicotine dependence	4.36e-05	0.000271	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—WASF2—nicotine dependence	4.35e-05	0.000271	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—DRD2—nicotine dependence	4.35e-05	0.00027	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	4.33e-05	0.000269	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—OPRM1—nicotine dependence	4.31e-05	0.000268	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	4.28e-05	0.000266	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—WASF1—nicotine dependence	4.17e-05	0.000259	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	4.15e-05	0.000258	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	3.98e-05	0.000247	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	3.97e-05	0.000247	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—DRD2—nicotine dependence	3.96e-05	0.000246	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—DRD2—nicotine dependence	3.95e-05	0.000246	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	3.89e-05	0.000242	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—WASF2—nicotine dependence	3.82e-05	0.000238	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	3.76e-05	0.000234	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	3.75e-05	0.000234	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—WASF2—nicotine dependence	3.75e-05	0.000233	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—WASF2—nicotine dependence	3.74e-05	0.000232	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	3.73e-05	0.000232	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	3.68e-05	0.000229	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—DRD2—nicotine dependence	3.67e-05	0.000228	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—DRD2—nicotine dependence	3.66e-05	0.000228	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—WASF1—nicotine dependence	3.66e-05	0.000228	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	3.61e-05	0.000225	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	3.6e-05	0.000224	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—WASF1—nicotine dependence	3.59e-05	0.000224	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—WASF1—nicotine dependence	3.58e-05	0.000223	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—DRD2—nicotine dependence	3.56e-05	0.000222	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	3.53e-05	0.000219	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	3.51e-05	0.000219	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—DRD2—nicotine dependence	3.51e-05	0.000218	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	3.42e-05	0.000213	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—DRD2—nicotine dependence	3.35e-05	0.000208	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	3.3e-05	0.000205	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	3.28e-05	0.000204	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	3.24e-05	0.000202	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—OPRM1—nicotine dependence	3.24e-05	0.000201	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—OPRM1—nicotine dependence	3.23e-05	0.000201	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	3.18e-05	0.000198	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—DRD2—nicotine dependence	3.16e-05	0.000196	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—DRD2—nicotine dependence	3.11e-05	0.000194	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	2.95e-05	0.000184	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—DRD2—nicotine dependence	2.71e-05	0.000169	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	2.7e-05	0.000168	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	2.34e-05	0.000146	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—DRD2—nicotine dependence	2.34e-05	0.000146	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—DRD2—nicotine dependence	2.33e-05	0.000145	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	2.3e-05	0.000143	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	2.13e-05	0.000133	CbGpPWpGaD
